Paid Clinical Trials in Lubbock, TX
As of July 2026, 104 paid clinical trials are recruiting in Lubbock, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Lubbock offers studies at sites including UMC Cancer Center / UMC Health System for conditions such as Crohn's Disease, Breast Cancer, Ulcerative Colitis, Grief. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Lubbock
Trials by drug in Lubbock
Filter results
Newly added in Lubbock
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
96 clinical trials
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Clinical Pre-screening Protocol for Ovarian Cancer
Evaluating the Efficacy of Blood Flow Restriction Therapy in a Randomized Clinical Trial for Postoperative Rehabilitation Following Ankle Ligament Reconstruction
Top Research Study Locations in Lubbock
Researchers run research studies in Lubbock, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| UMC Cancer Center / UMC Health System | B Acute Lymphoblastic Leukemia, Ganglioneuroblastoma, Nodular, Mixed Phenotype Acute Leukemia | 17 |
| Covenant Children's Hospital | B Acute Lymphoblastic Leukemia, Ganglioneuroblastoma, Nodular, Mixed Phenotype Acute Leukemia | 16 |
| Texas Tech University Health Sciences Center | Ankle Reconstruction, Anthracycline Related Cardiotoxicity in Breast Cancer, Bioavailability | 14 |
| Texas Tech University | Burden, Caregiver, Grief, Mental Health Issue | 9 |
| GI Alliance - Lubbock | Ulcerative Colitis, Colitis, Ulcerative, Crohn Disease | 4 |
| Covenant Medical Center | Central Line Associated Blood Stream Infections (CLABSI), Intracranial Atherosclerotic Stenosis (ICAS), Malignant Neoplasm | 3 |
| Joe Arrington Cancer Research & Treatment Center | Breast Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Melanoma | 3 |
| Texas Retina Associates | Epiretinal Membrane, Proliferative Diabetic Retinopathy (PDR), Radiation Retinopathy | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Covenant Children's Hospital- Joe Arrington Cancer Research and Treatment Center | Breast Cancer, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma | 2 |
| GI Alliance | C. Diff Infection, C.Difficile Diarrhea, CDI | 2 |
| Texas Digestive Disease Consultants dba GI Alliance - Lubbock | Crohn's Disease, Ulcerative Colitis | 2 |
| Texas Tech | Acute Kidney Injury, Chronic Kidney Disease(CKD), Epidemiology | 2 |
| Texas Tech University Health Science Center | Amblyopia | 2 |
| Texas Tech University Health Sciences Center-Lubbock | Breast Cancer, Stage I Breast Cancer | 2 |
| University Medical Center | Depression, Diabetes Mellitus, Diabetic Ketoacidosis | 2 |
| West Texas Clinical Research | Psoriatic Arthritis | 2 |
| Caprock Gastro Research | Colitis, Ulcerative, Crohn Disease, Crohn's Disease | 2 |
| Joe Arrington Cancer Research and Treatment Center | Multiple Myeloma, Diffuse Large B-Cell Lymphoma | 2 |
| Caprock Gastro Research - Lubbock | Crohn's Disease | 1 |
| Department of Kinesiology & Sport Management, Texas Tech University | Anabolic Resistance, Sarcopenia | 1 |
| GI Alliance - Bay Area Gastroenterology | Moderately to Severely Active Ulcerative Colitis | 1 |
| Garrison Institute on Aging | Mental Health Issue, Quality of Life | 1 |
| Global Aesthetics LLC | Wrinkle | 1 |
| Grace Medical Center | Lumbar Spinal Stenosis | 1 |
Active & Upcoming Studies in Lubbock (2026)
Recruiting trials in Lubbock grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (29 active studies)
- A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma · Phase 2 · Regeneron Pharmaceuticals
- A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer · Phase 3 · Hoffmann-La Roche
Diabetes & metabolic (5 active studies)
- Study of Patients Being Treated With Anti-obesity Medication · Texas Tech University
- Small Changes Clinical Weight Loss Trial · The University of Texas Health Science Center, Houston
Neurology & pain (4 active studies)
- Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients · Phase 4 · Texas Tech University Health Sciences Center
- Ginger Root Extract for Sciatic Pain Individuals · Phase 2 · Leslie Shen
Mental health & behavior (2 active studies)
- ACT for Individuals With MNCD and Their Care Partners · Phase 1 · Texas Tech University
- Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients · Phase 4 · Texas Tech University Health Sciences Center
Cardiovascular (1 active study)
- Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0 · Indiana University
Pediatric (1 active study)
- Speech Intervention Via Telepractice for Children With Repaired Cleft Palate · Texas Tech University Health Sciences Center
Common conditions studied in Lubbock
- Crohn's Disease (7 active studies)
- Breast Cancer (5 active studies)
- Ulcerative Colitis (5 active studies)
- Grief (3 active studies)
- Mental Health Issue (3 active studies)
- Amblyopia (2 active studies)
Leading research sponsors in Lubbock
- Texas Tech University Health Sciences Center
- Texas Tech University
- Children's Oncology Group
- National Cancer Institute (NCI)
- Jaeb Center for Health Research
Frequently asked questions
How many paid clinical trials are currently recruiting in Lubbock?
There are approximately 104 recruiting clinical trials in Lubbock, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Lubbock pay participants?
Most recruiting trials in Lubbock compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Lubbock?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Lubbock?
The most common conditions under active study in Lubbock include Crohn's Disease (7), Breast Cancer (5), Ulcerative Colitis (5), Grief (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Lubbock?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lubbock on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Lubbock?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Lubbock?
Recruiting research sites in Lubbock include UMC Cancer Center / UMC Health System, Covenant Children's Hospital, Texas Tech University Health Sciences Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Lubbock right now?
The largest active categories in Lubbock are Cancer & tumors (29), Diabetes & metabolic (5), Neurology & pain (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.